SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001415889-12-000617
Filing Date
2012-04-30
Accepted
2012-04-30 17:02:08
Documents
6
Period of Report
2012-04-30
Effectiveness Date
2012-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ectedef14aapr202012.htm DEF 14A 772653
2 proxycard1.jpg GRAPHIC 111006
3 proxycard2.jpg GRAPHIC 80546
4 kimberly1.jpg GRAPHIC 3673
5 graph.jpg GRAPHIC 48727
6 echo1.jpg GRAPHIC 585837
  Complete submission text file 0001415889-12-000617.txt   1917904
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35218 | Film No.: 12796006
SIC: 3845 Electromedical & Electrotherapeutic Apparatus